Infinity Pharmaceuticals, Inc. Current Assets
Infinity Pharmaceuticals, Inc. had Current Assets of $19.91 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-08-10
- 2023-06-30: Assets, Current $19.91M.
- 2023-03-31: Assets, Current $28.36M.
- 2022-12-31: Assets, Current $40.30M.
- 2022-09-30: Assets, Current $49.35M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2023-06-30 | $19.91M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $28.36M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $40.30M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $49.35M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $59.61M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $70.10M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $82.27M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $91.93M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $99.68M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $109.31M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $36.02M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $43.48M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $44.79M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $53.02M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $44.58M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $54.38M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $64.97M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $74.17M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $59.82M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $65.13M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $50.44M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $49.06M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $58.39M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $63.94M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $68.78M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $80.31M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $101.66M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $123.48M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $157.48M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $208.04M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $254.70M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $300.31M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $208.47M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $239.37M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $344.57M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $390.71M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $160.19M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $194.25M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $224.94M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $255.00M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $281.83M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $307.83M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $329.75M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $192.44M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $107.28M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $108.65M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $117.98M 10-K · filed 2013-03-05 | $117.98M 10-K · filed 2012-03-13 |
| 2011-09-30 | $78.43M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $84.89M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $103.13M 10-K · filed 2012-03-13 |